ResearchMoz

Dyslexia Global Clinical Trials Review, H1, 2013

GlobalData
Published Date » 2013-04-12
No. Of Pages » 59
 Dyslexia Global Clinical Trials Review, H1, 2013  Summary   GlobalData's clinical trial report, Dyslexia Global Clinical Trials Review, H1, 2013" provides data on the Dyslexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dyslexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. 
   
 The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dyslexia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house...
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Dyslexia 5
Symptoms of dyslexia are: 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by BRIC Nations 13
Clinical Trials by G7 Nations 14
Clinical Trials in G7 Nations by Trial Status 15
Clinical Trials by E7 Nations 16
Clinical Trials in E7 Nations by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Dyslexia 21
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Eli Lilly and Company 26
Clinical Trial Overview of Eli Lilly and Company 26
Clinical Trial Overview of Top Universities / Institutes / Hospitals 27
University Hospital, Tours 27
Clinical Trial Overview of University Hospital, Tours 27
Macquarie University 28
Clinical Trial Overview of Macquarie University 28
University of Tasmania 29
Clinical Trial Overview of University of Tasmania 29
University of Munster 30
Clinical Trial Overview of University of Munster 30
McGill University 31
Clinical Trial Overview of McGill University 31
University of Oxford 32
Clinical Trial Overview of University of Oxford 32
Vanderbilt University 33
Clinical Trial Overview of Vanderbilt University 33
Rabin Medical Center 34
Clinical Trial Overview of Rabin Medical Center 34
Five Key Clinical Profiles 35

Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 59

List of Tables


Dyslexia Therapeutics Market, Global, Clinical Trials by Zone, 2013* 6
Dyslexia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Dyslexia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 9
Dyslexia Therapeutics Clinical Trials, Europe, Top Countries, 2013* 10
Dyslexia Therapeutics Clinical Trials, North America, Top Countries, 2013* 11
Dyslexia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 12
Dyslexia Therapeutics Clinical Trials, BRIC Countries, 2013* 13
Dyslexia Therapeutics Clinical Trials, G7 Countries, 2013* 14
Dyslexia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 15
Dyslexia Therapeutics Clinical Trials, E7 Countries, 2013* 16
Dyslexia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 17
Dyslexia Therapeutics Market, Global, Clinical Trials by Phase, 2013* 18
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 19
Dyslexia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 20
Dyslexia Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 21
Dyslexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 22
Dyslexia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 24
Dyslexia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 25
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 26
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Tours, 2013* 27
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Macquarie University, 2013* 28
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tasmania, 2013* 29
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Munster, 2013* 30
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University, 2013* 31
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2013* 32
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2013* 33
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2013* 34

List of Figures


Dyslexia Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 6
Dyslexia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Dyslexia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 9
Dyslexia Therapeutics Clinical Trials, Europe, Top Countries (%), 2013* 10
Dyslexia Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 11
Dyslexia Therapeutics Clinical Trials, G7 Countries (%), 2013* 14
Dyslexia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 15
Dyslexia Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 18
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 19
Dyslexia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 20
Dyslexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 22
Dyslexia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 23
Dyslexia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 25
GlobalData Methodology 58

Upcoming Reports:

Poland: market of cultivators, scarifiers and rippers
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the cultivators, scarifiers and rippers market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the cultivators, scarifiers and rippers market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way,...
Ribbed Smoke Sheet Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
Ribbed smoke sheet is a natural rubber in a form of sheet which is used in various industries owing to its properties like tear strength and cleanliness. The main reason to smoke the rubber sheet is to improve its tensile strength. Ribbed smoke sheet market suffered a setback during 2008 – 2009 when the global economy was under pressure, but since then the global ribbed smoke market is growing at a healthy pace.  Some of the major factors which are contributing to the continuous growth of ribbed smoke sheet market include: the growth of global automotives market...
Polycyclohexylenedimethylene Terephthalate (PCT) Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2014 - 2020
By - Transparency Market Research
Polycyclohexylenedimethylene terephthalate (PCT) is typically a thermoplastic polyester produced from the polycondensation of cyclohexylene-dimethanol and terephthalic acid. The chemical structure of polycyclohexylenedimethylene terephthalate (PCT) is quite similar to that of polyethylene terephthalate (PET). Moreover, the properties of polycyclohexylenedimethylene terephthalate (PCT) such as dimensional stability and chemical resistance are same as that of polyethylene terephthalate (PET). Furthermore, PCT is principally resistant to hydrolysis and high temperatures. Owing to all such...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Ford Recalls 65,000 Fusion Models Due to Issues in Ignition Key
Nov 20, 2014  
If anything defines the world of automobiles currently, it would be recalls. It seems that a flood of automobiles has surrounded the global automobiles industry, which once represented a flourishing and highly profitable industry.  The current automobile giants ordering yet another recall is Ford Motors Co. Ford declared on Tuesday that it is recalling nearly 65,000 sedans from...
3D Printed Heart Model for Better Cardiological Treatment
Nov 20, 2014  
According to research carried out by the American Heart Association’s Scientific Sessions 2014, surgeons will be able to treat complex heart disorders in patients, with the help of a three dimensional experimental printed model of the heart. For surgical planning, most cardiac surgeons make use of two dimensional images of the heart taken by MRI, ultrasound, and X-ray. But the problem is...
Los Angeles Auto Show Kicks Off
Nov 20, 2014  
The Los Angeles Auto Show kicked off on Wednesday with a rather upbeat mood. Motoring machines, industry metrics, and hybrid models – the show has lived up to its reputation once more. The Los Angeles Auto Show has begun touring North America from the Los Angeles Convention Center, and the commencement has already had an impact on the market. Gasoline prices dropped under US$3...
Scottish Government to Inject 200 Million Pounds in the Housing Sector
Nov 19, 2014  
The construction and the housing industries of Scotland will get a major financial boost from the Scottish government in terms of additional funding worth 200 million pounds. The main rationale of such a financial boost is to stimulate the housing sector and also safeguarding employment in the construction industry. The housing minister of Scotland has requested the housing leaders to work...
Quarterly Dividend of $0.10 Declared by Tyson Foods, Inc.
Nov 19, 2014  
A quarterly dividend on November 18th was declared by Tyson Foods, reported Analyst Ratings Network.com. The shareholders of the February 27th record will be awarded a dividend of 0.10 per share on March 13th.  This represents a yield of 0.94% and a $0.40 dividend on an annualized basis. However, the ex-dividend date of this particular dividend is February 25th.  Such...